Association Between Calm1 Gene Polymorphisms And Osteoarthritis Risk: A Systematic Review And Meta-Analysis

Yangxin Wang,Fuhua Zhong,Jianqiao Hong,Jiahong Meng,Yute Yang,Shigui Yan,Wei Wang

2018-01-01

Abstract:Objective: The results of the association between CALM1 gene polymorphisms and osteoarthritis (OA) have been inconsistent. Our aim was to determine whether CALM1 rs12885713 and rs3213718 polymorphisms are associated with susceptibility to OA. Methods: PubMed, Embase, and ISI Web of Science databases were searched to identify relevant studies. Pooled odds ratios (ORs) with a 95% confidence interval (CI) were calculated to assess the association between CALM1 polymorphisms and OA susceptibility. We also conducted subgroup analysis stratified by ethnicity, OA site, and gender. Results: Five studies with 5051 participants (2292 OA patients and 2759 controls) were enrolled in this study. The combined results revealed no significant association between CALM1 rs12885713 polymorphism and OA risk (allele model: OR 1.09, 95% CI 0.98-1.21; dominant model: OR 1.10, 95% CI 0.93-1.30; recessive model: OR 1.41, 95% CI 0.88-2.26; homozygote model: OR 1.44, 95% CI 0.91-2.29; heterozygote model: OR 1.03, 95% CI 0.86-1.23). Subgroup analysis stratified by ethnicity suggested that TT genotype was associated with increased risk of OA in Asians (recessive model: OR 2.21, 95% CI 1.39-3.50; homozygote model: OR 2.20, 95% CI 1.37-3.54), but not in Caucasians. The pooled results revealed no significant association between CALM1 rs3213718 polymorphism and the risk of OA in the overall population or in each subgroup population. Conclusion: This meta-analysis suggested the TT genotype of CALM1 rs12885713 polymorphism significantly increased the risk of OA in Asians. In contrast, CALM1 rs3213718 polymorphism was not associated with OA risk. Due to the limitations of our study, further well-designed studies are required.